Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Human Genome Sciences
Human Genome Sciences
GlaxoSmithKline to Make a Bid for Human Genome Sciences?
Yahoo/Wall St. Cheat Sheet
Tue, 10/18/11 - 12:12 pm
GSK
Human Genome Sciences
M&A
With Earnings Around The Corner, Human Genome Continues To Drop
Seeking Alpha
Mon, 10/17/11 - 12:09 pm
earnings
Human Genome Sciences
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Gilead
Human Genome Sciences
Incyte
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Theravance
Biotech's Burning Questions for Q3 Earnings
TheStreet.com
Wed, 10/5/11 - 11:01 am
earnings
biotech
Dendreon
Vertex
Human Genome Sciences
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Achillion
Aeterna Zentaris
Antigenics
Ariad
Amylin
Amarin
BioDelivery Sciences
Cyclacel
Geron
Dendreon
PharmAthene
Zalicus
Human Genome Sciences
Keryx
Peregrine Pharmaceuticals
SIGA technologies
YM BioSciences
We Don't Care if It's the First Lupus Drug in 50 Years (in UK)
Motley Fool
Sat, 10/1/11 - 01:57 pm
lupus
Benlysta
Human Genome Sciences
GSK
This Week in Biotech
Motley Fool
Sat, 10/1/11 - 01:51 pm
Pharmasset
GSK
Human Genome Sciences
Vertex Pharmaceuticals
Optimer Pharmaceuticals
Cubist Pharmaceuticals
Array Biopharma
AstraZeneca
Human Genome slides on U.K. setback
MarketWatch
Sat, 10/1/11 - 12:34 pm
Human Genome Sciences
lupus
Benlysta
Human Genome Sciences stock falls as Britain denies funding for Benlysta
Bizjournals.com
Fri, 09/30/11 - 12:11 pm
Human Genome Sciences
UK
Benlysta
lupus
GSK
Biotech Investors Bow Out as Hurdles Grow
Bloomberg
Thu, 09/29/11 - 09:06 am
investors
Human Genome Sciences
Savient
biotech
Dendreon
Vertex
Acorda
Human Genome Spikes On Sales: Good Time To Consider Buying
Seeking Alpha
Mon, 09/26/11 - 10:56 am
Human Genome Sciences
GSK
Benlysta
lupus
Human Genome rallies 12% on lupus drug sales
Marketwatch
Wed, 09/21/11 - 11:25 pm
Human Genome Sciences
Benlysta
lupus
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
Human Genome Sciences
Vertex Pharmaceuticals
Lexicon Pharmaceuticals
Amarin
Exelixis
Dendreon
Acorda Therapeutics
Biotech Busts And Breakthroughs For August
Forbes
Thu, 09/1/11 - 11:34 am
Mako Surgical
Luminex
Regeneron
Pharmasset
ViroPharma
Dendreon
Pacific Biosciences
ZOLL Medical
Savient
Human Genome Sciences
Analyst says Human Genome's lupus treatment Benlysta receiving lukewarm reception from doctors
Yahoo/AP
Wed, 08/31/11 - 09:27 am
lupus
Benlysta
Human Genome Sciences
Human Genome Sciences: A Buy For High-Risk Takers
Seeking Alpha
Mon, 08/29/11 - 05:45 pm
Human Genome Sciences
Human Genome Sciences: Slow Benlysta Launch Results In Good Short Candidate
Seeking Alpha
Sun, 08/28/11 - 12:18 pm
Benlysta
Human Genome Sciences
lupus
GSK
Human Genome Evenly Poised
Yahoo/Zacks
Sat, 08/20/11 - 10:22 pm
Human Genome Sciences
12 Biotech Stocks the Insiders Are Buying
Motley Fool
Sat, 08/20/11 - 10:09 pm
Ligand
Halozyme
Ziopharm
OPKO Health
Theravance
Celgene
Human Genome Sciences
BioSante
Keryx
GTx
SIGA technologies
SciClone Pharmaceuticals
3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers
Marketwatch
Fri, 08/19/11 - 09:20 am
Dendreon
Provenge
Savient
Human Genome Sciences
Vertex Pharmaceuticals
InterMune
Seattle Genetics
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »